Afuco™ Anti-IFNA1 ADCC Therapeutic Antibody (Sifalimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human IFNA1. Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-H62 |
| Pricing | Inquiry |
| Host | Human |
| Target | IFNA1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IP, IF, FuncS, FC, Neut, ELISA |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |